Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-091366·DEJORIA JOHN PAUL
Schedule 13G ownership disclosure
TELOMIR PHARMACEUTICALS INC
Common Stock, no par value · CUSIP: 87975F104
Event date: 2025-09-09
- Filing-level shares
- 1,774,900.00
- Percent of class
- 5.50%
- John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity
Shares: 1,774,900.00 · Class: 5.50%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-091366
- Form type
- SCHEDULE 13G
- Filer
- DEJORIA JOHN PAUL
- CIK
- CIK 897610
- Filed
- Sep 18, 2025
- Reporting period
- Sep 09, 2025
- Description
- Schedule 13G beneficial ownership